Evidence map›Paper›PMID 11083636›Full record

ArticleAntimicrobial agents and chemotherapy2000

Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice.

G S Deepe, R Gibbons

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity.Journal of immunology (Baltimore, Md. : 1950) · 2009
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

G S DeepeDivision of Infectious Diseases, University of Cincinnati College of Medicine and the Veterans Affairs Hospital, Cincinnati, Ohio 45267-0560, USA. george.deepe@uc.edu
R Gibbons
University of Cincinnati Medical Center · US

Funding

PROTECTIVE ANTIGENS FROM HISTOPLASMA CAPSULATUMR01AI034361 · NIAID · UNIVERSITY OF CINCINNATI · PI DEEPE, GEORGE S. · 1993 to 2007
$2.5M
T CELL RECEPTOR USAGE IN PULMONARY HISTOPLASMOSISR37AI042747 · NIAID · UNIVERSITY OF CINCINNATI · PI DEEPE, GEORGE S. · 1997 to 2006
$2.2M
NIAID NIH HHS AI34361NIAID NIH HHS AI42747NIAID NIH HHS R01 AI034361NIAID NIH HHS R37 AI042747
6 · The paper itself

Abstract

Several endogenous cytokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF), are necessary for eliminating Histoplasma capsulatum from tissues. In this study, we explored the efficacy of recombinant murine GM-CSF in the treatment of pulmonary histoplasmosis. This cytokine significantly reduced fungal burden in a dose-dependent manner. Pretreatment did not consistently produce a better result than treatment started after infection. The biological effectiveness of GM-CSF was not associated with modulation of lung cytokine production or alteration in lung inflammation, but it directly activated a nonadherent lung cell population to exert anti-Histoplasma activity. GM-CSF improved survival of T-cell-depleted mice exposed to H. capsulatum. When combined with a suboptimal amount of amphotericin B, GM-CSF enhanced survival of normal or T-cell-depleted mice given a lethal challenge. These results suggest that this cytokine may be useful as an adjunctive treatment for histoplasmosis.

Indexed as

Amphotericin BAnimalsCytokinesDose-Response Relationship, DrugDrug InteractionsFlow CytometryGranulocyte-Macrophage Colony-Stimulating FactorHistoplasmaHistoplasmosisImmunocompetenceImmunocompromised HostLeukocytesLungMaleMiceMice, Inbred C57BLAmphotericin BCytokinesGranulocyte-Macrophage Colony-Stimulating FactorRecombinant Proteins

Identifiers

PMID11083636
PMCPMC90201
OpenAlexW2111049928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.